204 related articles for article (PubMed ID: 12900812)
1. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.
Nitta K; Akiba T; Uchida K; Kawashima A; Yumura W; Kabaya T; Nihei H
Am J Kidney Dis; 2003 Aug; 42(2):303-9. PubMed ID: 12900812
[TBL] [Abstract][Full Text] [Related]
2. Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients.
Nitta K; Akiba T; Uchida K; Otsubo S; Takei T; Yumura W; Kabaya T; Nihei H
Nephrol Dial Transplant; 2004 Jul; 19(7):1886-9. PubMed ID: 15128884
[TBL] [Abstract][Full Text] [Related]
3. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
Takei T; Otsubo S; Uchida K; Matsugami K; Mimuro T; Kabaya T; Akiba T; Nitta K
Nephron Clin Pract; 2008; 108(4):c278-83. PubMed ID: 18434749
[TBL] [Abstract][Full Text] [Related]
4. Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein.
Rhee EJ; Lee WY; Kim SY; Kim BJ; Sung KC; Kim BS; Kang JH; Oh KW; Oh ES; Baek KH; Kang MI; Woo HY; Park HS; Kim SW; Lee MH; Park JR
Clin Sci (Lond); 2005 Mar; 108(3):237-43. PubMed ID: 15569000
[TBL] [Abstract][Full Text] [Related]
5. Plasma osteoprotegerin is associated with mortality in hemodialysis patients.
Morena M; Terrier N; Jaussent I; Leray-Moragues H; Chalabi L; Rivory JP; Maurice F; Delcourt C; Cristol JP; Canaud B; Dupuy AM
J Am Soc Nephrol; 2006 Jan; 17(1):262-70. PubMed ID: 16280472
[TBL] [Abstract][Full Text] [Related]
6. Serum fibroblast growth factor-23 levels and progression of aortic arch calcification in non-diabetic patients on chronic hemodialysis.
Tamei N; Ogawa T; Ishida H; Ando Y; Nitta K
J Atheroscler Thromb; 2011; 18(3):217-23. PubMed ID: 21139318
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis.
Yamada K; Fujimoto S; Nishiura R; Komatsu H; Tatsumoto M; Sato Y; Hara S; Hisanaga S; Ochiai H; Nakao H; Eto T
Nephrol Dial Transplant; 2007 Jul; 22(7):2032-7. PubMed ID: 17395663
[TBL] [Abstract][Full Text] [Related]
8. Predictors of abdominal aortic calcification progression in patients with chronic kidney disease without hemodialysis.
Yamamoto D; Suzuki S; Ishii H; Hirayama K; Harada K; Aoki T; Shibata Y; Negishi Y; Tatami Y; Sumi T; Ichii T; Kawashima K; Kunimura A; Kawamiya T; Morimoto R; Yasuda Y; Murohara T
Atherosclerosis; 2016 Oct; 253():15-21. PubMed ID: 27573734
[TBL] [Abstract][Full Text] [Related]
9. The relationship between poor nutritional status and progression of aortic calcification in patients on maintenance hemodialysis.
Okamoto T; Hatakeyama S; Kodama H; Horiguchi H; Kubota Y; Kido K; Momota M; Hosogoe S; Tanaka Y; Takashima T; Saitoh F; Suzuki T; Ohyama C
BMC Nephrol; 2018 Mar; 19(1):71. PubMed ID: 29558928
[TBL] [Abstract][Full Text] [Related]
10. Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis.
Nitta K; Akiba T; Suzuki K; Uchida K; Watanabe R; Majima K; Aoki T; Nihei H
Am J Kidney Dis; 2004 Oct; 44(4):680-8. PubMed ID: 15384019
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of osteoprotegerin in hemodialysis patients.
Avbersek-Luznik I; Malesic I; Rus I; Marc J
Clin Chem Lab Med; 2002 Oct; 40(10):1019-23. PubMed ID: 12476941
[TBL] [Abstract][Full Text] [Related]
12. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
Okamoto T; Hatakeyama S; Hosogoe S; Tanaka Y; Imanishi K; Takashima T; Saitoh F; Suzuki T; Ohyama C
PLoS One; 2018; 13(7):e0199160. PubMed ID: 29969455
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis.
Mazzaferro S; Pasquali M; Pugliese F; Barresi G; Carbone I; Francone M; Sardella D; Taggi F
Am J Nephrol; 2007; 27(1):75-83. PubMed ID: 17259697
[TBL] [Abstract][Full Text] [Related]
15. Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis.
Bezerra MC; Calomeni GD; Caparbo VF; Gebrim ES; Rocha MS; Pereira RM
Rheumatology (Oxford); 2005 Dec; 44(12):1503-6. PubMed ID: 16219645
[TBL] [Abstract][Full Text] [Related]
16. Association between pentosidine and arteriosclerosis in patients receiving hemodialysis.
Kitauchi T; Yoshida K; Yoneda T; Saka T; Yoshikawa M; Ozono S; Hirao Y
Clin Exp Nephrol; 2004 Mar; 8(1):48-53. PubMed ID: 15067516
[TBL] [Abstract][Full Text] [Related]
17. Association of conjunctival and corneal calcification with vascular calcification in dialysis patients.
Seyahi N; Altiparmak MR; Kahveci A; Yetik H; Kanberoglu K; Serdengecti K; Ataman R; Erek E
Am J Kidney Dis; 2005 Mar; 45(3):550-6. PubMed ID: 15754277
[TBL] [Abstract][Full Text] [Related]
18. Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal osteodystrophy in dialysis patients.
Grzegorzewska AE; Mlot M
Adv Perit Dial; 2005; 21():188-93. PubMed ID: 16686316
[TBL] [Abstract][Full Text] [Related]
19. [Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients].
Masho Y; Shigematsu T
Clin Calcium; 2007 Mar; 17(3):354-9. PubMed ID: 17339739
[TBL] [Abstract][Full Text] [Related]
20. Improved assessment of aortic calcification in Japanese patients undergoing maintenance hemodialysis.
Ohya M; Otani H; Kimura K; Saika Y; Fujii R; Yukawa S; Shigematsu T
Intern Med; 2010; 49(19):2071-5. PubMed ID: 20930432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
